These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4403107)

  • 1. Spinal monoamines and the toxic interaction between monoamine oxidase inhibitors and tricyclic antidepressants.
    Clineschmidt BV
    Eur J Pharmacol; 1972 Jul; 19(1):126-9. PubMed ID: 4403107
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of tricyclic antidepressants and 5-hydroxyindolealkylamine precursors on spinal monosynaptic reflex transmission.
    Clineschmidt BV; Pierce JE; Sjoerdsma A
    J Pharmacol Exp Ther; 1971 Nov; 179(2):312-23. PubMed ID: 4332325
    [No Abstract]   [Full Text] [Related]  

  • 4. The blockade of bulbospinal inhibition by imipramine, desipramine and pargyline.
    Sinclair JG; Sastry BS
    Neuropharmacology; 1974 Jul; 13(7):643-50. PubMed ID: 4155054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of centrally acting drugs on spinal reflex potentials].
    Matsumiya T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):218-39. PubMed ID: 5066298
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z; Kraus P
    Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
    Meek JL; Fuxe K
    Biochem Pharmacol; 1971 Mar; 20(3):693-706. PubMed ID: 5150164
    [No Abstract]   [Full Text] [Related]  

  • 8. Bulbospinal serotonin-containing neurons and motor control.
    Anderson EG
    Fed Proc; 1972; 31(1):107-12. PubMed ID: 4333246
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of L-3,4-dihydroxyphenylalanine on spinal reflex activity.
    Baker RG; Anderson EG
    J Pharmacol Exp Ther; 1970 May; 173(1):212-23. PubMed ID: 5442299
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic antidepressives--a possible mode of action.
    Offermeier J; Potgieter B
    S Afr Med J; 1969 Nov; 43(45):1366-70. PubMed ID: 5358038
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord.
    Santini M; Berl S
    Brain Res; 1972 Nov; 47(1):167-76. PubMed ID: 4641266
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.